• Radicicol Hsp90 Inhibitor Workflows

  2026-08-08

  Radicicol is a mechanistic Hsp90 inhibitor for dissecting antigen cross-presentation, adipocyte differentiation, apoptosis, and inflammatory signaling. This practical guide connects target-selective assay design with formulation, dosing, controls, and troubleshooting across cellular and in vivo models.

• PHF2, Neuroinflammation, and Alzheimer’s Disease

  2026-08-07

  Yang and colleagues identify the histone demethylase PHF2 as an epigenetic regulator of inflammatory gene expression in Alzheimer’s disease. Across human tissue, patient-derived neurons, and 5xFAD mice, PHF2 reduction was associated with lower neuroinflammation, improved synaptic function, and better spatial memory, while also highlighting important limits for therapeutic translation.

• Imatinib Hydrochloride in Cancer Research: Optimizing Workfl

  2026-08-07

  Imatinib hydrochloride (STI571 hydrochloride) stands as a gold-standard, multi-target tyrosine kinase inhibitor empowering translational cancer research. This article delivers practical protocol enhancements, troubleshooting strategies, and key mechanistic insights to maximize the reproducibility and impact of chronic myelogenous leukemia and gastrointestinal stromal tumor studies.

• Tivozanib (AV-951): Precision VEGFR Inhibition in Cancer Ass

  2026-08-06

  Explore how Tivozanib (AV-951) enables ultra-selective VEGFR signaling pathway inhibition for advanced anti-angiogenic therapy research. This article reveals mechanistic insights, rigorous protocol parameters, and new perspectives for optimizing renal cell carcinoma treatment models.

• γH2AX DNA Damage Detection Kit: Precision in DSB Assessment

  2026-08-06

  The γH2AX DNA Damage Detection Kit enables sensitive detection of DNA double-strand breaks (DSBs) using γ-H2AX as a biomarker. This kit supports robust DNA damage and repair research, with high specificity validated in oncology and genotoxicity contexts. Its streamlined workflow offers reproducible and quantitative results across mammalian models.

• Phosbind Biotin LC: Practical Western Blot Phosphorylation D

  2026-08-05

  Phosbind Biotin LC is a phosphate-binding reagent designed for sequence-independent detection of phosphorylated proteins on PVDF membranes, addressing gaps where phospho-specific antibodies are unavailable or insufficient. It is not suitable for aqueous-only protocols or workflows requiring long-term storage of working solutions.

• Nerve Regulation of HDAC1 in Axolotl Limb Regeneration

  2026-08-05

  This study uncovers a nerve-dependent mechanism regulating histone deacetylase 1 (HDAC1) expression, which is crucial for blastema formation and successful limb regeneration in axolotls. Through pharmacological inhibition and nerve factor supplementation, the research delineates the central role of HDAC1 and neural input in orchestrating regenerative epigenetic states, providing a model for investigating HDAC-mediated plasticity in vertebrate tissues.

• Capecitabine in Preclinical Oncology: Applied Assays and Tro

  2026-08-04

  Capecitabine (N4-pentyloxycarbonyl-5'-deoxy-5-fluorocytidine) underpins advanced tumor-targeted drug delivery and apoptosis modeling in complex assembloid systems. This guide details actionable protocols, troubleshooting strategies, and the translational edge offered by APExBIO’s high-purity Capecitabine for preclinical oncology research.

• ATRX Deficiency Sensitizes Glioma to Selective PDGFRα/β Inhi

  2026-08-04

  The reference study demonstrates that ATRX-deficient high-grade glioma cells display heightened sensitivity to receptor tyrosine kinase and PDGFR inhibitors. These findings highlight the importance of ATRX mutational status as a determinant of therapeutic response and provide a rationale for integrating selective PDGFRα/β inhibitors into tailored glioma research.

• Tyrothricin Peptide Antibiotic Mixture: Advanced Research Wo

  2026-08-03

  Tyrothricin’s unique peptide composition delivers robust, reproducible antimicrobial effects in experimental studies targeting bacterial, fungal, and viral pathogens. This guide translates the latest mechanistic insights into practical, step-wise workflows to optimize Tyrothricin’s use for membrane-targeted antimicrobial assays, troubleshooting, and cross-domain infection models.

• γH2AX DNA Damage Detection Kit: Precision DSB Detection in O

  2026-08-03

  The γH2AX DNA Damage Detection Kit (Mouse mAb/Red) from APExBIO empowers researchers with robust, high-sensitivity immunofluorescence assays for DNA double-strand break detection and repair analysis. Learn how this kit streamlines workflows, enhances genotoxicity assessment, and supports advanced applications like radioimmunotherapy optimization.

• Flumequine as a Precision Tool for Quantifying Topoisomerase

  2026-08-02

  Explore Flumequine, a potent DNA topoisomerase II inhibitor, as a rigorous standard for in vitro quantification of drug responses in cancer and DNA replication research. This article uniquely focuses on assay optimization, reproducibility, and decision-making, informed by the latest methodological advances.

• Anlotinib Hydrochloride: Applied Strategies for Anti-Angioge

  2026-08-01

  Anlotinib hydrochloride stands out as a next-generation, multi-target tyrosine kinase inhibitor ideal for dissecting angiogenesis and tumor progression. This guide delivers actionable protocols, troubleshooting insights, and comparative analysis to maximize success in preclinical cancer research workflows.

• Capecitabine in Tumor-Stroma Assembloids: Mechanism to Strat

  2026-07-31

  This thought-leadership article explores how Capecitabine (N4-pentyloxycarbonyl-5'-deoxy-5-fluorocytidine) empowers translational researchers to interrogate apoptosis induction and chemotherapy selectivity in advanced assembloid models. By integrating mechanistic insights, evidence from patient-derived gastric cancer models, and actionable guidance, we chart a path for leveraging Capecitabine’s tumor-selective properties in complex preclinical workflows. The article distinguishes itself by connecting product intelligence with emerging tumor microenvironment paradigms and offers a forward-looking perspective on assembling robust, translationally relevant data.

• Standardized Whole-Blood Stimulation Sheds Light on Immunome

  2026-07-31

  The reference study introduces a standardized protocol for analyzing immune responses in human whole blood with metabolic modulation, enabling precise evaluation of how cellular metabolism shapes cytokine profiles. This methodological advance supports reproducible immuno-oncology research and informs therapeutic strategies targeting metabolic pathways.

8421 records 3/562 page Previous Next 12345 下5页 Last page